Long-term prognosis of patients with variant angina.
نویسندگان
چکیده
منابع مشابه
Factors influencing the clinical course and the long-term prognosis of patients with variant angina.
The purpose of this study was to clarify the factors influencing the clinical course and prognosis in variant angina. Also, the mechanism of acute myocardial infarction in variant angina is reviewed. The subjects were 110 patients with variant angina who, after the initial visit or admission, were observed for a period of at least 2 months, the average observation period being 68 +/- 49 months ...
متن کاملLong-term prognosis for patients with variant angina and influential factors.
Two hundred forty-five patients with variant angina were followed for an average of 80.5 months (range, 36-184 months). Survival rate at 1, 3, 5, and 10 years was 98%, 97%, 97%, and 93%, respectively. Survival rate without myocardial infarction at 1, 3, 5, and 10 years was 86%, 85%, 83%, and 81%, respectively. By univarite analysis, ST segment elevation in both the anterior and inferior electro...
متن کاملPlasma choline, smoking, and long-term prognosis in patients with stable angina pectoris.
BACKGROUND Plasma choline has been associated with cardiovascular disease and nonalcoholic steatohepatitis. DESIGN We sought to study relations of plasma choline and its metabolite betaine to long-term risk of acute myocardial infarction (AMI) and all-cause mortality according to smoking status, in patients undergoing coronary angiography for stable angina pectoris. METHODS Samples were obt...
متن کاملLong-term survival in patients with refractory angina.
AIMS An increasing number of patients with severe coronary artery disease (CAD) are not candidates for traditional revascularization and experience angina in spite of excellent medical therapy. Despite limited data regarding the natural history and predictors of adverse outcome, these patients have been considered at high risk for early mortality. METHODS AND RESULTS The OPtions In Myocardial...
متن کاملSudden Death in Patients with Variant Angina
ergic blocking effects of iproveratril. Can J Physiol Pharmacol 43: 339, 1965 22. Greenberg S, Wilson WR: Iproveratril: a nonspecific antagonist of peripheral vascular reactivity. Can J Physiol Pharmacol 52: 266, 1974 23. Ross G, Jorgensen CR: Cardiovascular actions of iproveratril. J Pharmacol Exp Ther 158: 504, 1967 24. Rowe GG, Stenlund RR, Thomsen JH, Corliss RJ, Sialer S: The systemic and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 1987
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.76.5.990